First Global Conference on Cardiovascular Clinical Trials and Pharmacotherapy - 2nd WHF Global Conference on Cardiovascular Clinical Trials and 13th International Society of Cardiovascular Pharmacotherapy Congress ISCP

 (October 1-3, 2004, Hong Kong)

 


 

 

FOREWORD

The First Gobal Conference on Cardiovascular Clinical Trials and Pharmacotherapy was held in Hong Kong, China from October 1-2, 2004. This meeting had incorporated the 2rd World Heart Federation Global Conference on Cardiovascular Clinical Trials and 13th International Society of Cardiovascular Pharmacotherapy Congress. This meeting provided a gateway for scientific exchange among scientists and physicians from different parts of world on cardiovascular clinical trials and pharmacotherapy.
In the recent decades, there is a significant progress in the understanding of the pathophysiology, diagnosis and treatment of cardiovascular diseases. The conference has provided an update on recent findings on cardiovascular clinical trials, which is the cornerstone of good practice of evidence-based medicine, as well as advances in new therapies derived from the most recent drug and therapeutic discoveries.
The purpose of this proceeding is to summarize some of the selected materials that have been presented in the Conference such that interested individuals can obtain in-depth of review these presentations. It is sincerely hoped that this proceeding will provide a concise overview on recent updates and practice of cardiovascular therapies.

 


 

INDEX

 

Invited Lectures

 

Treatment Strategy for Japanese Hypertensive Patients with Coronary Artery Disease. Comparative Effects of Nifedipine Retard vs. ACE-Inhibitors Results of JMIC-B Study
C. Kawai

New Treatment of Myocarditis and Heart Failure
A. Matsumori

Effects of Cardiovascular Drugs on Uric Acid in Cardiovascular Medicine: New Paradigm
A.J. Reyes

Antithrombotic Therapy in Atrial Fibrillation
J. Tomson and G.Y.H. Lip

 

 

Free Papers

 

Effects of Diacetyl-linesinine on Ion Currents in Ventricular Myocytes
F. Cao, C.X. Huang, H. Jiang, T. Wang and X. Li

Remodeling of L-Type Calcium Current in Various Stages of Human Atrial Fibrillation
Congxin Huang, Gang Wu, Hong Jiang, Qizhu Tang, Zhengrong Huang, Qiang Xie and Yanhong Tang

Impairment of Quality of Life in Patients with Atrial Fibrillation
P.-Y. Sin, H.-F. Tse, C.-W. Siu, V. Tsang, C.K.L. Lam and C.-P. Lau

Successful Pulmonary Vein Isolation Using Transvenous Catheter Cryoablation Improves Quality-of-Life in Patients with Atrial Fibrillation
P.-Y. Sin, H.-F. Tse, C.-W. Siu, V. Tsang, C.L.K. Lam and C.-P. Lau

EvaluAtion of Resynchronization Therapy for Heart failure (EARTH) study
B. Thibault, F. Harel, A. Ducharme, M. White, D. Roy, J.L. Rouleau, F. Philippon, P. Dorian, M. Dubuc, P.G. Guerra, P. Khairy, L. Macle and M. Talajic

Utility of theLevel of Brain Natriuretic Peptide in Plasma for the Evaluation of Cardiac Function in Chronic Left Heart Failure Treatment with -Blockers
Fang Wang, Xiaoru Chen, Wei Li, Zhimin Xu and Yishi Li

Remodeling of Transient Outward Potassium Current During Development of Human Atrial Fibrillation
Gang Wu, Congxin Huang, Zhengrong Huang, Qizhu Tang,
Hong Jiang, Qiang Xie and Yanhong Tang

Nifedipine Retard Is as Effective as ACE-I for Hypertension in Diabetics / The JMIC-B Subgroup Analysis
Y. Yui

Nifedipine Suppresses the Progression of Coronary Atherosclerosis / The JMIC-B Side Arm Study
Y. Yui

Mast Cells Contribute to Angiogenesis after Coronary Microembolization
Q.-Y. Zhang, H.-F. Tse, J.-Z. Chen, Q.-G. Zhang and J.-B. Ge

Inhibitory Effect of Clopidogrel on Platelet Aggregation in CHD Patients
Xiuli Zhao, DayiHu, jie Xiao, Hong Bian and Tianchang Li

 MEDIMOND s.r.l. - Via Verdi, 15/1 - 40067 Pianoro (BO) Italy